Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.
Ontology highlight
ABSTRACT: Prior exposure to lipopolysaccharide (LPS) produces a reduced or "tolerant" inflammatory response to subsequent challenges with LPS, however the potent pro-inflammatory effects of LPS limit its clinical benefit. The adjuvant monophosphoryl lipid A (MPLA) is a weak toll-like receptor 4 (TLR4) agonist that induces negligible inflammation but retains potent immunomodulatory properties. We postulated that pre-treatment with MPLA would inhibit the inflammatory response of endothelial cells to secondary LPS challenge. Human umbilical vein endothelial cells (HUVECs), were exposed to MPLA (10 μg/ml), LPS (100 ng/ml) or vehicle control. HUVECs were then washed and maintained in culture for 24 h before being challenged with LPS (100 ng/ml). Supernatants were collected and examined for cytokine produ
SUBMITTER: Stark RJ
PROVIDER: S-EPMC4744094 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA